《Table 2Operative data of the study patients.》

《Table 2Operative data of the study patients.》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Efficacy of octreotide in the prevention of complications after pancreaticoduodenectomy in patients with soft pancreas and non-dilated pancreatic duct: A prospective randomized trial》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录

There was no significant difference between the two groups regarding the baseline characteristics（Table 1）.Operative data of the patients were shown in Table 2.There was no significant difference between the two groups.The postoperative data of the patients were shown in Table 3.There was no significant difference between the 2 groups regarding total hospital stay（P=0.421），the total days of naso-gastric tube use（P=0.834），time of starting oral intake（P=0.964），postoperative morbidities（P=0.839），and its severity（P=0.715）.POPF occurred in 11 patients（21.2%）in group I，and in 10 patients（19.2%）in group II，and this was statistically non-significant（P=0.807）.There were no significant differences between the 2 groups regarding grades of POPF（P=0.891），and clinically-relevant pancreatic fistula（P=1.000）.Also，there were no significant differences between the 2 groups regarding the incidence of biliary leakage（P=0.083），delayed gastric emptying（P=0.472），and early postoperative mortality（P=0.727）.

图表编号XD0020448900    严禁用于非法目的
绘制时间2018.02.01
作者Ayman El Nakeeb、Ahmed El Gawalby、Mahmoud A.Ali、Ahmed Shehta、Hosam Hamed、Mohamed El Refea、Ahmed Moneer、Ahmed Abd El Rafee
绘制单位Gastroenterology Surgical Center, Mansoura University、Gastroenterology Surgical Center, Mansoura University、Gastroenterology Surgical Center, Mansoura University、Gastroenterology Surgical Center, Mansoura University、Gastroenterology Surgical Center, Manso
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 1 Demographics of patients with inflammatory bowel disease included in the studies》2019.07.28
  2. 《Table 1 Clinical data of patients in this study》2019.03.26
  3. 《Table 1.Data of 196 hemophilia patients involved in this study》2019.02.20
  4. 《Table 1.Clinical data of the patients in 3 three groups》2019.02.20
  5. 《Table 1.Demographic data of patients with the adverse reactions.》2019.01.01
  6. 《Table 1.The major (%) , trace element and REE (×10–6) data of the samples from WPSP of this study》2019.01.01
  7. 《Table 2 Preoperative clinical data of the eyes included in the study in both subgroups》2019.04.18
  8. 《Table 5 Genotype-Phenotype correlations of the patients included in the study》2019.04.18
  9. 《Table 2 The raw data with BCVA and VF of the included studies》2019.01.18
  10. 《Table 2Operative data.》2019.02.15
  11. 《Table 2 List of the Landsat data[22]used in this study》2018.12.24
  12. 《Table 1 Clinical data of patients in the 2 groups》2018.05.01
  13. 《Table 1 Clinical data of patients in the 2 groups》2018.05.01
  14. 《Table 1 Clinical data of patients in the 2 groups》2018.05.01
  15. 《Table 1 Demographic data and clinical profile of the recruited patients》2018.04.01
  16. 《Table 1 Data of the patients at the baseline visit[1]》2018.12.18
  17. 《Table 2Intraoperative and postoperative data of the patients in this study.》2018.10.15
  18. 《Table 3Postoperative outcomes of the study patients.》2018.02.01
  19. 《Table 1Baseline characteristics of included patients in the study (n=18 948) .》2018.02.01
  20. 《Table 1Baseline characteristics of the study patients.》2018.02.01

随机翻阅

《表1 布隆迪IMBO和MOSO试验点土壤状况》 《表2 样本基本情况与变量描述性统计分析》 《表6 R&D经费投入中政府资金和企业资金及占比》 《表一东周时期提链壶的结链方式信息》 《表1 分子鉴定情况：猪丹毒杆菌分离鉴定及体外抑菌试验》 《表3 相关性检验：市值管理、融资约束与上市公司研发投入——来自通信设备制造行业的经验证据》 《表1 A组与B组患者临床疗效评分比较》 《Table 4 Phosphate coating weight and Ra of E-coating》 《表2 三种竹醋溶液处理的吸水量与失水量统计值》 《表2 青稞HtLTP1基因启动子顺式作用元件》